Kawasaki disease: multiple giant coronary aneurysms intervention and pacemaker implantation due to complete heart

Chunping Liu1, Junxia Li1, Zhenshuang Cui1

  • 1Department of Cardiovascular Disease, General Hospital of PLA Army, Beijing 100700, China.

Insights

Early treatment for Kawasaki disease (KD) is crucial. This case highlights severe complications like giant coronary artery aneurysms and heart block in a patient with delayed diagnosis and treatment.

Area of Science:

  • Pediatrics
  • Cardiology
  • Immunology

Background:

  • Kawasaki disease (KD) requires early intravenous immunoglobulin (IVIG) to prevent coronary artery aneurysms (CAAs).
  • Delayed diagnosis or atypical presentations, common in rural areas, increase complication risk.
  • Effective management of giant CAAs compromising cardiac function remains challenging.

Observation:

  • A 19-month-old girl presented with atypical symptoms, leading to delayed KD diagnosis and IVIG treatment.
  • She developed multivessel giant CAAs (>8 mm), acute myocardial infarction, and complete heart block.
  • Percutaneous coronary intervention (PCI) was unsuccessful in restoring flow to the affected coronary artery.

Findings:

  • Despite late IVIG, the patient experienced severe cardiac complications, including giant CAAs and myocardial infarction.
  • Persistent bradycardia necessitated permanent pacemaker implantation.
  • The patient demonstrated clinical stability at 12-month follow-up post-pacemaker insertion.

Implications:

  • This case underscores the critical need for timely KD diagnosis and treatment, especially in atypical or remote cases.
  • It highlights the limitations of standard treatments in managing severe, giant CAAs and associated cardiac dysfunction.
  • The successful management with a pacemaker suggests a viable option for long-term cardiac support in such complex pediatric cases.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
519
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
545
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
256
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
302
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
558